OBR News Hub – OBR
© Caribou Publishing. All rights reserved. Reproduction in whole or in part is prohibited.
Related Articles
FDA Approves Nivolumab/Ipilimumab in First-Line Hepatocellular Cancer
Findings from the CheckMate 9DW trial support the FDA approval of nivolumab and ipilimumab in unresectable hepatocellular carcinoma
What you need to know as the May 7 Real ID deadline approaches
Driver’s licenses and IDs that are not Real ID-compliant will no longer get you through U.S. airport security once the law takes effect in a…
Beam Therapeutics Announces Positive Initial Data for BEAM-302 in the Phase 1/2 Trial in Alpha-1 Antitrypsin Deficiency (AATD), Demonstrating First Ever Clinical Genetic Correction of a Disease-causing Mutation
Single Dose of BEAM-302 Led to Durable, Dose-dependent Increases in Total and Functional Alpha-1 Antitrypsin (AAT), Production of Corrected M-AAT, and…
Health Rounds: Vaccine keeps advanced kidney cancer from recurring
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small early-stage trial,…
Small personalized vaccine trial sees progress in late-stage kidney cancer
All nine late-stage kidney cancer patients in a Phase 1 trial of a personalized vaccine remained cancer-free after more than three years of receiving treatment,…
Cancer vaccine shows promise for patients with stage III and IV kidney cancer | Dana-Farber Cancer Institute
All nine patients treated at Dana-Farber Cancer Institute in a phase 1 trial of a personalized cancer vaccine for patients with stage III or IV…
Home
With novel radiopharmaceutical therapies entering clinical trials and into clinical practice, the 2025 Transatlantic Exchange in Oncology will focus on bringing together key experts from…
Felix Feng, Giant in the Field of Prostate Cancer, Dies at 48
Renowned radiation oncologist Felix Y. Feng, MD, passed away from cancer on Dec. 10, 2024, at the age of 48.